CSI Market
Sign In | Register

Lixte Biotechnology Holdings Inc (LIXT) Annual Balance Sheets

Annual · GAAP · USD millions
Access LIXT quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Lixte Biotechnology Holdings Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.11
Cash & Short-term Investments5.00
Other Current Assets0.03
Total loans net0.04
Total Current Assets5.18
Equipment/Property/Plant Net6.58
Other Assets, Noncurrent0.97
Advances On Research And Development Contract Services-
Total Assets12.73
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.44
Other Liabilities, Current0.90
Total Current Liabilities1.33
Total Long-term Debt0.00
Other liabilities, Noncurrent0.44
OperatingLeaseLiabilityNoncurrent0.44
Research And Development Contract Liabilities Current0.23
Total Liabilities1.77
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock66.01
Retained Earnings / Accumulated Deficit-58.08
Other Equity1.73
Common Stockholder's Equity9.66
Preferred Stockholder's Equity0.00
Non-controlling interests & other1.30
Total Stockholder's Equity10.96
Liabilities & Stockholder's Equity12.73
4 historic quarters locked

Sign in to unlock the full Lixte Biotechnology Holdings Inc balance sheet history.

Sign In Create Free Account

About Lixte Biotechnology Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014052

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.